Network intelligence for Lundbeck’s new drugs
January 2013. The success of its new drugs against alcohol abuse critically depends on the Danish drugmaker's capability to outbeat generics and more distinctive improvements than other branded therapeutics after market launch. Time is tight for Andreas Eggert and Barbara Jaszewski, his new colleague for global Pricing and Market Access.Reading time: 2 min
Read Now: |
Other articles recommended
B2Bioworld offers you background information
Innovation – Try Again, Fail Again, Fail Better
Ulrich Betz, Vice President Department Head Innovation & Entrepreneurship Incubator; Merck Biopharma
Personalised Medicine: Let’s be clear what it means
Jonathan K.C. Knowles, at the time Head of Group Research Roche about his motivations, work in Roche, and competitors